Summary Plan Description (SPD)

Summary Plan Description (SPD) refers to a crucial document in the context of employer-sponsored 401(k) retirement plans. As a legally mandated communication, the SPD serves as an essential resource for employees, outlining the key features and provisions of their retirement benefits package. It is designed to provide clear and concise information about the plan, ensuring participants understand their rights, responsibilities, and available investment options.

The SPD typically covers various aspects of the 401(k) plan, such as eligibility criteria, contribution limits, vesting schedules, and the process for making withdrawals or loans from the account. Additionally, it informs employees about the employer's matching contributions, if applicable, and any other employer-specific benefits related to the retirement plan.

Examples of what an SPD might include:

  • Eligibility Requirements: The SPD will specify the conditions an employee must meet to become eligible for participation in the 401(k) plan. For instance, it might state that an employee must work a certain number of hours per week or complete a specific waiting period before enrolling.
  • Investment Options: Employees need a comprehensive understanding of their investment choices within the 401(k) plan. The SPD will outline the various investment funds available, along with their respective risk profiles and potential returns.
  • Vesting Schedule: The SPD may explain the vesting schedule for employer contributions. For instance, it could indicate that an employee becomes fully vested in the employer's matching contributions after five years of service.

In conclusion, the Summary Plan Description (SPD) plays a vital role in educating employees about the intricacies of their employer-sponsored 401(k) plan, empowering them to make informed decisions to secure their financial future.

Next Up

According to Mployer Insights’ 2026 analysis of 76,000+ employer benefit plans, disability insurance remains a major market differentiator, with only 41% of U.S. employers offering short-term disability (STD) and 38% offering long-term disability (LTD). While 60% salary replacement serves as the national standard across both benefit types, standard plan designs disproportionately expose higher earners due to median benefit caps of $1,602/week for STD and $8,273/month for LTD. Furthermore, alignment between STD benefit durations (median 26 weeks) and LTD elimination periods (68% at 90 days) remains a critical area for plan structure optimization.
Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.